Novartis’s Multiple Sclerosis Pill Faces FDA Review ... - Bloomberg

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service88 times read : Adjust font size: Decrease font Enlarge font
image

Merck, based in Darmstadt, Germany, said today it resubmitted the drug for U.S. approval. Immune System Attack Multiple sclerosis affects about 2.5 million people, according to the National Multiple Sclerosis Society in the U.S., causing the body to ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright